Alejandro Hernández-Camba Selected Research

Alejandro Hernández-Camba Research Topics

5	Crohn Disease (Crohn's Disease) 01/2024 - 12/2013
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2023 - 07/2017
2	Latent Tuberculosis 11/2018 - 07/2017
1	Pouchitis 01/2024
1	Atherosclerosis 03/2023
1	Ulcerative Colitis 01/2023
1	Pulmonary Embolism 01/2023
1	Thrombosis (Thrombus) 01/2023
1	COVID-19 12/2022
1	Inflammation (Inflammations) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Abdominal Obesity 07/2021
1	Necrosis 07/2017
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2013

3	Triglycerides (Triacylglycerol)IBA 03/2023 - 07/2021
2	LipidsIBA 03/2023 - 01/2022
2	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 08/2022
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022 - 07/2017
2	Tuberculin (PPD)IBA 11/2018 - 07/2017
1	C-Reactive ProteinIBA 03/2023
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2023
1	vedolizumabIBA 01/2023
1	tofacitinibIBA 01/2023
1	COVID-19 VaccinesIBA 12/2022
1	VaccinesIBA 12/2022
1	Apolipoprotein C-IIIIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	SteroidsIBA 07/2017
1	Azathioprine (Imuran)FDA LinkGeneric 12/2013

2	Therapeutics 01/2024 - 07/2017